Karenitecin, characterized as a formidable topoisomerase I inhibitor, exhibits robust anti-cancer effects. It instigates DNA damage and elevates the protein expression of cyclin E and cdk2 in A253 cells.
Products > ADC Linker, ADC Payload > ADC Payload | Products > ADC Linker, ADC Payload > ADC Payload > Karenitecin
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.
日本语
한국어
Français
Deutsch
España
Türkiye